Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies

Philip Mendez, Alanis Rosado, Juan Carlos Cardet

Open source

DOI
10.1007/s11882-026-01294-1
Published
2026-09-16
Container
Current Allergy and Asthma Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11882-026-01294-1,
  title = {Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies},
  author = {Philip Mendez and Alanis Rosado and Juan Carlos Cardet},
  year = {2026},
  journal = {Current Allergy and Asthma Reports},
  doi = {10.1007/s11882-026-01294-1},
  url = {https://doi.org/10.1007/s11882-026-01294-1}
}

RIS

TY  - JOUR
TI  - Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies
AU  - Philip Mendez
AU  - Alanis Rosado
AU  - Juan Carlos Cardet
PY  - 2026
JO  - Current Allergy and Asthma Reports
DO  - 10.1007/s11882-026-01294-1
UR  - https://doi.org/10.1007/s11882-026-01294-1
ER  - 

APA

Mendez, P., Rosado, A., & Cardet, J. C. (2026). Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies. Current Allergy and Asthma Reports. https://doi.org/10.1007/s11882-026-01294-1

Source records